InvestorPlace - Stock Market News, Stock Advice & Trading Tips
MRNA stock could be at full value here if analysts' projections for lower sales in 2023 come to pass, despite a potential rebound by Q4 2023.
The post Analysts See a Dip and Then a Rebound In Moderna’s Future appeared first on InvestorPlace.
More From InvestorPlace